Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Clinical guidelines for the prevention and treatment of osteoporosis from the Italian Society for Orthopaedics and Traumatology: preface

A population aging process is over in Italy, as in most developed countries. Over time, the average age has risen and the percentage of the population above retirement age has increased. This change is bound to have significant consequences for society, families and individuals. The increase in life expectancy will increase the cost of care, as people aged >65 years are using more health services than those aged <65 years. The higher incidence of age-related diseases, such as cancer, cardiovascular disease and dementia, involves the high cost associated with senile illnesses. It is estimated that in 2050, over 33% of the general population will be aged >65 years, compared to the current 21%. Life expectancy in 2050 will be 85.3 years for men and 90.2 years for women. This involves an increase of the frail elderly, i.e., older people who are chronically affected by multiple pathologies, with an unstable, often disabled, state of health. Frailty has a high risk of rapid deterioration of health and functional status, including diseases such as sarcopenia and osteoporosis. Aging of the Italian population, with an increase of life expectancy by 20–26% in the last 20 years [1], has led to a higher incidence and prevalence of age-related diseases, such as osteoporosis. In Italy, osteoporosis potentially affects 5,000,000 people, of whom 80% are women of post-menopausal age. In particular, it is estimated that 1 out of 3 women and 1 out of 8 men in the >50 population are affected by this disease. Osteoporosis is characterized by an increased risk of experiencing a ‘fragility fracture’. Osteoporosis fractures can lead to important consequences, such as hospitalization followed by long periods of immobility, need of surgical treatment, increased disability and partial or complete loss of autonomy in daily activities [2]. It must then be considered that the presence of a fragility fracture represents a major risk factor for a subsequent fracture, with rates increasing by 2- to 5-fold, as reported by an Italian group [3]. The demographic structure of a country and the analysis of its perspective evolution, are the basis for a correct health policy [4]. Osteoporosis is a priority that the Italian National Health System has to face urgently. An active, not ‘on demand,’ medical service requires intense prevention and long-term care campaigns. Efficient and accurate diagnostic and therapeutic programs, based on comprehensive knowledge of bone tissue genetics, pathophysiology and metabolism, constitute a fundamental support to clinical practice. Fragility fractures represent a dramatic epilogue in the natural history of osteoporosis, as they undermine a patient’s quality of life while burdening the health system. Costs are very high; estimates for the year 2002, in fragility fracture patients aged >65 years, show that expenses are related both to surgical treatment and rehabilitation, while total costs for the year 2006 are estimated to be about 1,000,000,000 € in the same population. Despite its high prevalence (4.7 million people affected in Italy), osteoporosis is perceived as a less severe disease, with respect to acute myocardial infarction and diabetes, both by public opinion and primary care physicians [5]. Consequently, often incorrect and superficial management has led to an increase in fracture incidence and, as a domino effect, in the incidence of re-fractures. Today, fragility fractures still represent an underdiagnosed and undertreated condition [6]. The orthopaedic surgeon is often the first doctor who should recognize bone fragility. This is the basis for the Italian Society of Orthopaedics and Traumatology (SIOT; Società Italiana di Ortopedia e Traumatologia) to develop guidelines on osteoporosis and bone fragility for its members [7].

The document predisposed by a multidisciplinary group of experts represents a useful component in the efforts made in Italy in the past decade. The recommendations were constructed on levels of evidence, based on published works, with tool-boxes useful for a quick consultation. Moreover, the proposal for the creation of Fracture Units (or Fracture Liaison Services) for the therapeutic continuity of bone fragile patients is generously presented and discussed, in an unprecedented way. We are confident that our efforts will be appreciated by our readers.


  1. Italian National Institute for Statistics (ISTAT) Report 2016. Accessed 17 July 2017

  2. Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30(4):637–646. doi:10.1002/jbmr.2393

    Article  PubMed  Google Scholar 

  3. Nuti R, Brandi ML, Isaia G, Tarantino U, Silvestri S, Adami S (2009) New perspectives on the definition and the management of severe osteoporosis: the patient with two or more fragility fractures. J Endocrinol Invest 32(9):783–788. doi:10.3275/6436

    Article  CAS  PubMed  Google Scholar 

  4. Lindsay R, Silverman SL, Cooper C et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323

    Article  CAS  PubMed  Google Scholar 

  5. Piscitelli P, Brandi ML, Tarantino U et al (2010) Incidence and socioeconomic burden of hip fractures in Italy: extension study 2003–2005. Reumatismo 62:113–118

    CAS  PubMed  Google Scholar 

  6. Siris ES, Modi A, Tang J, Gandhi S, Sen S (2014) Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis. Curr Med Res Opin 30(1):123–130. doi:10.1185/03007995.2013.851074

    Article  PubMed  Google Scholar 

  7. Brandi ML, Guglielmi G, Masala S, Minisola S, Ortolani S, Tarantino U, Simonetti G (2012) When the government actively faces the burden of osteoporosis: the Italian experience. Arch Osteoporos 7:21–24. doi:10.1007/s11657-012-0077-0

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations



SG wrote the Preface.

Corresponding author

Correspondence to Giuseppe Sessa.

Ethics declarations

Conflict of interest

The author declares that he has no conflict of interest to disclose relevant to the subject of this article.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.


Publication of this article was funded by the Società Italiana di Ortopedia e Traumatologia (SIOT).

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sessa, G. Clinical guidelines for the prevention and treatment of osteoporosis from the Italian Society for Orthopaedics and Traumatology: preface . J Orthop Traumatol 18 (Suppl 1), 1–2 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI: